1. Home
  2. JAMF vs RCUS Comparison

JAMF vs RCUS Comparison

Compare JAMF & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAMF
  • RCUS
  • Stock Information
  • Founded
  • JAMF 2002
  • RCUS 2015
  • Country
  • JAMF United States
  • RCUS United States
  • Employees
  • JAMF N/A
  • RCUS N/A
  • Industry
  • JAMF Computer Software: Prepackaged Software
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAMF Technology
  • RCUS Health Care
  • Exchange
  • JAMF Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • JAMF 1.4B
  • RCUS 1.2B
  • IPO Year
  • JAMF 2020
  • RCUS 2018
  • Fundamental
  • Price
  • JAMF $11.47
  • RCUS $12.03
  • Analyst Decision
  • JAMF Buy
  • RCUS Buy
  • Analyst Count
  • JAMF 11
  • RCUS 8
  • Target Price
  • JAMF $16.27
  • RCUS $20.71
  • AVG Volume (30 Days)
  • JAMF 2.1M
  • RCUS 711.9K
  • Earning Date
  • JAMF 11-06-2025
  • RCUS 11-05-2025
  • Dividend Yield
  • JAMF N/A
  • RCUS N/A
  • EPS Growth
  • JAMF N/A
  • RCUS N/A
  • EPS
  • JAMF N/A
  • RCUS N/A
  • Revenue
  • JAMF $666,382,000.00
  • RCUS $262,000,000.00
  • Revenue This Year
  • JAMF $14.24
  • RCUS N/A
  • Revenue Next Year
  • JAMF $9.60
  • RCUS N/A
  • P/E Ratio
  • JAMF N/A
  • RCUS N/A
  • Revenue Growth
  • JAMF 11.36
  • RCUS 6.07
  • 52 Week Low
  • JAMF $7.09
  • RCUS $6.50
  • 52 Week High
  • JAMF $18.77
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • JAMF 82.41
  • RCUS 66.27
  • Support Level
  • JAMF $9.11
  • RCUS $11.30
  • Resistance Level
  • JAMF $11.58
  • RCUS $12.05
  • Average True Range (ATR)
  • JAMF 0.49
  • RCUS 0.58
  • MACD
  • JAMF 0.22
  • RCUS 0.02
  • Stochastic Oscillator
  • JAMF 94.44
  • RCUS 81.30

About JAMF Jamf Holding Corp.

Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: